Cardiovascular disease remains a leading driver of morbidity and cost, especially in the southeastern US, home of the “Stroke Belt.” This session spotlights how one Stroke Belt state harnessed its statewide health information exchange to quantify population and patient-level cardio kidney metabolic (CKM) risk while uncovering geographic and treatment patterns. Participants will hear findings from a statewide baseline study of heart health that catalyzed traction across multiple provider organizations while earning recognition from payers and large employers—an essential ingredient for a whole ecosystem approach.
Attendees will see practical innovation and tactics for health systems to more efficiently identify, prioritize, and manage CKM-related risk, with a clear line of sight to NCQA quality standards, including blood pressure control, ultimately improving care and outcomes for patients. Content will be tailored for health system quality leaders, primary care networks, payers, and employer groups. Leave with practical playbooks, implementation tips, and collaboration strategies to replicate and scale CKM risk stratification and quality improvement in your market.
Ryan Cork, University of Arkansas for Medical Sciences (UAMS)
Rich Krutsch, Abett
Meredith Brantley, AstraZeneca